NUVL as of Oct 31 · 20:19 ET
NUVLNasdaqPharmaceutical Preparations
Nuvalent, Inc. · Brief
Next report
4 days
Nov 5 · before openest.Q3 FY26
Expected move
No implied move.
1 of 7≥ implied
- avg implied
- ±7.5%
- avg realized
- ±3.9%
Aug 8 '24—▲+4.15%—
Nov 12 '24±4.4%▼−3.60%×0.82
Feb 27 '25±7.6%▼−2.76%×0.36
May 8 '25±7.6%▲+7.31%×0.97
Aug 7 '25±6.4%▼−6.56%×1.03
Q3 FY25±13.6%▼−4.66%×0.34
Q1 FY26±8.0%▼−0.57%×0.07
May 7 '26±5.1%▼−1.78%×0.35
quarterimplied−15%0+15%realized×
May '26±5.1%▼−1.78%×0.35
Q1 FY26±8.0%▼−0.57%×0.07
Q3 FY25±13.6%▼−4.66%×0.34
Aug '25±6.4%▼−6.56%×1.03
May '25±7.6%▲+7.31%×0.97
Feb '25±7.6%▼−2.76%×0.36
2 older reports
Nov '24±4.4%▼−3.60%×0.82
Aug '24—▲+4.15%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.Bull2 of 3
Bear1
AI captions · Oct 7 '26once per report · top 2 per case
Linked exposure
NUVL report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.